Mod­er­na's new Covid-19 vac­cine analy­sis 'giv­ing weight' to an­nu­al boost­ing in­ter­val, com­pa­ny says

Mod­er­na’s Covid-19 vac­cine study sug­gests a longer in­ter­val be­tween boost­ers is more ben­e­fi­cial in the gen­er­al adult pop­u­la­tion, sup­port­ing the FDA’s pre­vi­ous pro­pos­al for an …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.